Akums Drugs and Pharmaceuticals has received approval from the Drug Controller General of India (DCGI) for a triple combination diabetes medication. The drug combines Sitagliptin 100, Pioglitazone 15, and Metformin 1000/500 to provide better treatment without the need for multiple drugs.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/EdLWl3y
via IFTTT
0 comments:
Post a Comment